Ariola, Fidel .
HRN: 04-09-06 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/06/2025
05/13/2025
IV
4.5 G
Q8h
Diabetic Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes